Aroa Biosurgery Limited (ASX: ARX)
Australia
· Delayed Price · Currency is AUD 0.720
+0.020 (2.86%)
Dec 4, 2024, 4:10 PM AEST
Aroa Biosurgery Cash Flow Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2018 |
| Net Income | -7.62 | -10.63 | -0.4 | -8.39 | -19.21 | -5.96 | Upgrade
|
| Depreciation & Amortization | 4.4 | 4.4 | 3.83 | 3.13 | 3.05 | 2.72 | Upgrade
|
| Other Amortization | - | - | - | 0.05 | 1.61 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.01 | 0 | 0 | -0.03 | Upgrade
|
| Stock-Based Compensation | 3.18 | 3.18 | 2.58 | 2.97 | 1.99 | 0.42 | Upgrade
|
| Other Operating Activities | 1.81 | 2.39 | 0.11 | 1.35 | 8.13 | 5.62 | Upgrade
|
| Change in Accounts Receivable | 0.9 | 0.9 | -2.24 | -8.35 | -0.49 | -1.68 | Upgrade
|
| Change in Inventory | -3.27 | -3.27 | -2.75 | -0.32 | 0.63 | -1.33 | Upgrade
|
| Change in Accounts Payable | 0.11 | 0.11 | 1.84 | 1.32 | -0.3 | 2.27 | Upgrade
|
| Change in Income Taxes | -0.03 | -0.03 | -0.39 | 0.09 | 0.41 | -0.36 | Upgrade
|
| Change in Other Net Operating Assets | -4.42 | -4.42 | -6.39 | -3.38 | -0.83 | -0.03 | Upgrade
|
| Operating Cash Flow | -4.94 | -7.38 | -3.77 | -11.52 | -5.01 | 1.66 | Upgrade
|
| Capital Expenditures | -2.98 | -3.52 | -6.03 | -4.46 | -1.27 | -1.69 | Upgrade
|
| Sale (Purchase) of Intangibles | -3 | -3.46 | -1.58 | -0.42 | -0.24 | -0.18 | Upgrade
|
| Investment in Securities | 22 | 17.13 | 14.87 | -30 | -20 | - | Upgrade
|
| Investing Cash Flow | 16.02 | 10.15 | 7.26 | -34.87 | -21.5 | -1.87 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 1.78 | Upgrade
|
| Long-Term Debt Repaid | - | -0.74 | -0.65 | -10.09 | -12.92 | -7.88 | Upgrade
|
| Net Debt Issued (Repaid) | -0.85 | -0.74 | -0.65 | -10.09 | -12.92 | -6.1 | Upgrade
|
| Issuance of Common Stock | 0.07 | 0.11 | 0.17 | 50.32 | 34.95 | 0.3 | Upgrade
|
| Other Financing Activities | -0.42 | -0.41 | -0.03 | -2.6 | 15.07 | 5.42 | Upgrade
|
| Financing Cash Flow | -1.2 | -1.03 | -0.5 | 37.63 | 37.1 | -0.38 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.23 | 0.24 | 0.4 | -0.46 | 0.94 | -0.01 | Upgrade
|
| Net Cash Flow | 9.65 | 1.98 | 3.38 | -9.22 | 11.53 | -0.61 | Upgrade
|
| Free Cash Flow | -7.92 | -10.9 | -9.8 | -15.98 | -6.27 | -0.03 | Upgrade
|
| Free Cash Flow Margin | -10.37% | -15.78% | -15.47% | -40.26% | -28.07% | -0.12% | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.03 | -0.03 | -0.05 | -0.02 | -0.01 | Upgrade
|
| Cash Interest Paid | 0.49 | 0.49 | 0.38 | 1.73 | 1.26 | 0.58 | Upgrade
|
| Cash Income Tax Paid | 0.76 | 0.27 | 0.57 | 0.02 | -0.23 | 0.16 | Upgrade
|
| Levered Free Cash Flow | -10.59 | -11.84 | -11.88 | -13.56 | -8.58 | 2.56 | Upgrade
|
| Unlevered Free Cash Flow | -10.27 | -11.53 | -11.64 | -12.84 | -7.39 | 4.42 | Upgrade
|
| Change in Net Working Capital | 5.77 | 5.45 | 8.5 | 9.34 | 6.32 | -4.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.